Director, Single-cell Analytics Innovation Lab (SAIL)

Memorial Sloan Kettering Cancer Center | Ex: Weill Cornell Medicine

LinkedIn

About

Cancer biologist and genomics innovator with 15+ years developing and deploying multiomic technologies at the intersection of fundamental discovery and translational oncology. Director of SAIL (core genomics facility) at MSKCC, leads a team of 16 scientists (wet and dry lab) supporting 80+ research programs annually; co-developer of single-cell technologies, h-index 36; NIH co-PI

Work history

Associate Lab Member, Sloan Kettering Institute

Memorial Sloan Kettering Cancer Center

2023 – Present

Director, Single-cell Analytics Innovation Lab (SAIL)

Memorial Sloan Kettering Cancer Center

2020 – Present

Leads a team of 16 scientists supporting 80+ research programs annually; drives platform evaluation and technology adoption across single-cell, spatial, and sample processing modalities.

Assistant Lab Member, Sloan Kettering Institute

Memorial Sloan Kettering Cancer Center

2020 – 2023

Postdoctoral Fellow, Landau Laboratory

Weill Cornell Medicine

2016 – 2020

Co-developed GoT (Genotyping of Transcriptomes, Nature 2019) and Smart-RRBS (Nature Protocols 2021) for single-cell profiling of DNA methylome, transcriptome, and genotype.

Postdoctoral Fellow, Heard Laboratory

Institut Curie

2010 – 2016

Demonstrated epigenetic instability of the inactive X chromosome in breast cancer; developed expertise in cancer epigenetics and chromatin regulation.

I

Doctoral Researcher

Institut Gustave Roussy / Université Paris XI

2005 – 2009

Identified MPL W515L/K mutations in hematopoietic stem cells as disease-initiating events in myeloproliferative neoplasms.

Expertise

Industry
1
Life Sciences & Biotech
Department
3
Biotech & Pharma R&DHealth Economics & Market AccessR&D & Innovation